| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.006 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |